Jpmorgan Chase & CO Jazz Pharmaceuticals PLC Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding JAZZ
# of Institutions
500Shares Held
57.4MCall Options Held
155KPut Options Held
152K-
Vanguard Group Inc Valley Forge, PA6.32MShares$692 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.15MShares$672 Million0.02% of portfolio
-
Lsv Asset Management Chicago, IL2.48MShares$271 Million0.58% of portfolio
-
Capital World Investors Los Angeles, CA2.02MShares$221 Million0.04% of portfolio
-
State Street Corp Boston, MA2.02MShares$221 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.86B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...